PTPRC and neoplasm: The trans-differentiation of tumor cells into endothelial-like cells, which were CD45− CD31+ CD34+ (termed tumor-derived endothelial cells, TDECs) [61] and GSCs that were CD133+CD144+ [62] initiated and promoted VM in GBM models.